EP0618923A4 - PEPTIDE NUCLEIC ACIDS AND THEIR EFFECT ON GENETIC MATERIAL. - Google Patents

PEPTIDE NUCLEIC ACIDS AND THEIR EFFECT ON GENETIC MATERIAL.

Info

Publication number
EP0618923A4
EP0618923A4 EP93901215A EP93901215A EP0618923A4 EP 0618923 A4 EP0618923 A4 EP 0618923A4 EP 93901215 A EP93901215 A EP 93901215A EP 93901215 A EP93901215 A EP 93901215A EP 0618923 A4 EP0618923 A4 EP 0618923A4
Authority
EP
European Patent Office
Prior art keywords
effect
nucleic acids
genetic material
peptide nucleic
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93901215A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0618923A1 (en
Inventor
Stephen A Thomson
Stewart A Noble
Daniel J Ricca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of EP0618923A1 publication Critical patent/EP0618923A1/en
Publication of EP0618923A4 publication Critical patent/EP0618923A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003Peptide-nucleic acids (PNAs)
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP93901215A 1991-12-18 1992-12-17 PEPTIDE NUCLEIC ACIDS AND THEIR EFFECT ON GENETIC MATERIAL. Withdrawn EP0618923A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80966191A 1991-12-18 1991-12-18
US809661 1991-12-18
PCT/US1992/010921 WO1993012129A1 (en) 1991-12-18 1992-12-17 Peptide nucleic acids and their effect on genetic material

Publications (2)

Publication Number Publication Date
EP0618923A1 EP0618923A1 (en) 1994-10-12
EP0618923A4 true EP0618923A4 (en) 1998-05-20

Family

ID=25201908

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93901215A Withdrawn EP0618923A4 (en) 1991-12-18 1992-12-17 PEPTIDE NUCLEIC ACIDS AND THEIR EFFECT ON GENETIC MATERIAL.

Country Status (10)

Country Link
EP (1) EP0618923A4 (no)
JP (1) JPH07502509A (no)
AU (2) AU3325493A (no)
CA (1) CA2125966A1 (no)
FI (1) FI942935A (no)
MX (1) MX9207334A (no)
NO (1) NO942327D0 (no)
NZ (1) NZ246473A (no)
WO (1) WO1993012129A1 (no)
ZA (1) ZA929764B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228982B1 (en) * 1992-05-22 2001-05-08 Benget Norden Double-stranded peptide nucleic acids
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US6441130B1 (en) 1991-05-24 2002-08-27 Isis Pharmaceuticals, Inc. Linked peptide nucleic acids
US6713602B1 (en) 1991-05-24 2004-03-30 Ole Buchardt Synthetic procedures for peptide nucleic acids
US7223833B1 (en) 1991-05-24 2007-05-29 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
US6451968B1 (en) 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
US6277603B1 (en) 1991-12-24 2001-08-21 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
US5700922A (en) * 1991-12-24 1997-12-23 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
ATE515510T1 (de) * 1991-12-24 2011-07-15 Isis Pharmaceuticals Inc Durch dna-abschnitte unterbrochene modifizierte oligonukleotide
US6350853B1 (en) 1993-04-26 2002-02-26 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
US5527675A (en) * 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
DE4331012A1 (de) * 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
WO1995017403A1 (en) * 1993-12-22 1995-06-29 Perseptive Biosystems, Inc. Guanine synthons for peptide nucleic acid synthesis and method for production
US6133444A (en) 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DK145493D0 (da) * 1993-12-23 1993-12-23 Dako As Antistof
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
DE4408531A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe
DE4408533A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer basenlabilen Amino-Schutzgruppe
DE4408534A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag Substituierte N-Ethyl-Glycinderivate zur Herstellung von PNA und PNA-/DNA-Hybriden
DE4427980A1 (de) * 1994-08-08 1996-02-15 Bayer Ag Nukleinsäuren-bindende Oligomere für Therapie und Diagnostik
EP0804456B1 (en) * 1994-10-06 2002-08-21 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
WO1996020212A2 (en) * 1994-12-28 1996-07-04 Buchardt, Dorte Peptide nucleic acid incorporating a chiral backbone
US6465650B1 (en) 1995-03-13 2002-10-15 Aventis Pharma Deutschland Gmbh Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
JP2001518054A (ja) * 1995-06-07 2001-10-09 パーセプティブ バイオシステムズ,インコーポレーテッド Pna−dnaキメラと、このキメラ合成用のpnaシントン
AU7016096A (en) * 1995-10-20 1997-05-07 Trustees Of Boston University Nucleic acid clamps
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
AU8147798A (en) * 1997-06-16 1999-01-04 University Of North Carolina At Chapel Hill, The Peptido oligonucleotides (pons) and their combinatorial libraries
AU9064598A (en) * 1998-07-10 2000-02-01 Harald Groger Precusors for pna-monomers
US6921812B1 (en) 2001-07-03 2005-07-26 Isis Pharmaceuticals, Inc. Methods of modulating pharmacokinetics of oligonucleotides
KR20050088079A (ko) 2002-11-15 2005-09-01 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
WO2007073149A1 (en) 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
WO2012113775A1 (en) 2011-02-21 2012-08-30 University Of Zurich Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
EP2971160B1 (en) 2013-03-15 2018-05-30 Bio-Rad Laboratories, Inc. Digital assays for mutation detection
JP2020511550A (ja) * 2017-03-23 2020-04-16 トゥルーコード ジーン リペアー, インコーポレイテッド 直交保護エステル部分を有するペプチド核酸(pna)モノマー

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005518A1 (en) * 1985-03-15 1986-09-25 James Summerton Stereoregular polynucleotide-binding polymers
WO1992020702A1 (en) * 1991-05-24 1992-11-26 Ole Buchardt Peptide nucleic acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005518A1 (en) * 1985-03-15 1986-09-25 James Summerton Stereoregular polynucleotide-binding polymers
WO1992020702A1 (en) * 1991-05-24 1992-11-26 Ole Buchardt Peptide nucleic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9312129A1 *

Also Published As

Publication number Publication date
NO942327L (no) 1994-08-17
FI942935A (fi) 1994-07-27
AU3325493A (en) 1993-07-19
MX9207334A (es) 1993-08-01
FI942935A0 (fi) 1994-06-17
ZA929764B (en) 1993-10-13
WO1993012129A1 (en) 1993-06-24
NO942327D0 (no) 1994-06-17
CA2125966A1 (en) 1993-06-24
JPH07502509A (ja) 1995-03-16
EP0618923A1 (en) 1994-10-12
AU7032596A (en) 1997-01-16
NZ246473A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
EP0618923A4 (en) PEPTIDE NUCLEIC ACIDS AND THEIR EFFECT ON GENETIC MATERIAL.
PL310677A1 (en) Pharmaceutical agents based on nucleic acids
GB9115909D0 (en) Recombinant dna
IL109774A0 (en) Recombinant dna, vectors and host organisms containing them, and transgenic plants containing the recombinant dna
NO943344L (no) MN-gen og -protein
IL197834A0 (en) Polypeptides and nucleic acids encoding the same
IL99496A0 (en) Onco-fetal gene,its protein product and their uses
GB9310472D0 (en) Phenylalanine-free protein and dna coding thereof
EP0578819A4 (en) Icam-related protein.
EP0767797A4 (en) PLANT PEPTIDE TRANSPORT GENE
EP0669396A4 (en) Novel polypeptides and DNA coding for them.
EP0363436A4 (en) CLONED GENES OF PROTEIN G VARIANTS AND PROTEIN G VARIANTS EXPRESSED BY THESE GENES.
EP0626971A4 (en) Recombinant gibberellin dna and uses thereof.
ZA918423B (en) Proteins and nucleic acids.
ZA894800B (en) Proteins and nucleic acids
EP0600278A3 (en) Protein and gene of the glutamate receptor.
ZA988460B (en) Polypeptides and nucleic acids encoding the same
SG70981A1 (en) Platelet glycoprotein v gene and uses
GB9105446D0 (en) Proteins and nucleic acids
GB9310227D0 (en) Protein and dna
GB9217881D0 (en) Protein and nucleic acids
GB9116325D0 (en) Proteins and nucleic acids
GB9202401D0 (en) Proteins and nucleic acids
GB9512092D0 (en) Proteins and nucleic acids
GB9122330D0 (en) Dna sequence and polypeptide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940608

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GLAXO WELLCOME INC.

A4 Supplementary search report drawn up and despatched

Effective date: 19980403

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990419

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19991230